HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells
暂无分享,去创建一个
P. Delvenne | J. Somja | S. Demoulin | P. Hubert | P. Roncarati | M. Herfs
[1] J. Blay,et al. Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment. , 2013, Cancer research.
[2] B. Schmidt,et al. Identification of novel oligonucleotides from mitochondrial DNA that spontaneously induce plasmacytoid dendritic cell activation , 2013, Journal of leukocyte biology.
[3] M. Lotze,et al. HMGB1 in Cancer: Good, Bad, or Both? , 2013, Clinical Cancer Research.
[4] P. Delvenne,et al. Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms , 2013, Journal of leukocyte biology.
[5] D. Rosenberg,et al. Multifaceted roles of PGE2 in inflammation and cancer , 2013, Seminars in Immunopathology.
[6] J. Blay,et al. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. , 2012, Cancer research.
[7] G. Siegal,et al. Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells , 2012, The Journal of Immunology.
[8] H. Zeng,et al. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection. , 2012, Human immunology.
[9] J. Blay,et al. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. , 2012, Cancer research.
[10] A. Westendorf,et al. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. , 2012, International immunology.
[11] J. Blay,et al. Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis , 2012, Oncoimmunology.
[12] H. Møller,et al. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma , 2012, Cancer.
[13] S. Lang,et al. HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer. , 2012, Oral oncology.
[14] P. Delvenne,et al. Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34(+) hematopoietic progenitor cells: use of interleukin-3. , 2012, Experimental hematology.
[15] J. Blay,et al. Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. , 2011, Cancer research.
[16] J. Wagner,et al. Generation and Large‐Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft‐Versus‐Host Disease , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] Ziqiang Zhu,et al. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. , 2011, The Journal of clinical investigation.
[18] P. Delvenne,et al. Mucosal junctions: open doors to HPV and HIV infections? , 2011, Trends in microbiology.
[19] H. Radzun,et al. Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma , 2010, BMC Cancer.
[20] S. Dow,et al. Type I interferons inhibit the generation of tumor-associated macrophages , 2010, Cancer Immunology, Immunotherapy.
[21] T. Giese,et al. Tumour‐derived prostaglandin E2 and transforming growth factor‐β synergize to inhibit plasmacytoid dendritic cell‐derived interferon‐α , 2009, Immunology.
[22] R. Dina,et al. Immunopathology and Infectious Diseases Correlation of CXCL 12 Expression and FoxP 3 Cell Infiltration with Human Papillomavirus Infection and Clinicopathological Progression of Cervical Cancer , 2010 .
[23] Chunhua Lu,et al. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels. , 2009, Croatian medical journal.
[24] Hoguen Kim,et al. Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers , 2009, Laboratory Investigation.
[25] Yi Luo,et al. Suppression of Dendritic Cells by HMGB1 Is Associated with Lymph Node Metastasis of Human Colon Cancer , 2009, Pathobiology.
[26] P. Delvenne,et al. Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? , 2009, Trends in molecular medicine.
[27] P. Delvenne,et al. High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells , 2009, Cancer Immunology, Immunotherapy.
[28] E. Butcher,et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. , 2009, Biochemical and biophysical research communications.
[29] P. Delvenne,et al. Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. , 2008, The American journal of pathology.
[30] I. Mellman,et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.
[31] F. Belardelli,et al. Interferon-α and cancer : Mechanisms of action and new perspectives of clinical use , 2007 .
[32] P. Delvenne,et al. MIP3 alpha stimulates the migration of Langerhans cells in models of human papillomavirus (HPV)-associated (pre)neoplastic epithelium , 2007, Cancer Immunology, Immunotherapy.
[33] A. Scarpa,et al. Cooperative Induction of a Tolerogenic Dendritic Cell Phenotype by Cytokines Secreted by Pancreatic Carcinoma Cells1 , 2006, The Journal of Immunology.
[34] X. Shao,et al. Influence of IFN- alpha and IFN- gamma on lymphangiogenesis. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[35] R. Schreiber,et al. A critical function for type I interferons in cancer immunoediting , 2005, Nature Immunology.
[36] Peter P. Nawroth,et al. Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1 , 2005, The Journal of Immunology.
[37] P. Lenz,et al. Papillomavirus virus‐like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells , 2005, European journal of immunology.
[38] A. Mantovani,et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin , 2005, The Journal of experimental medicine.
[39] G. Trinchieri,et al. Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.
[40] J. Blay,et al. Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer , 2004, Clinical Cancer Research.
[41] P. Carmeliet,et al. Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer , 2004, Cancer Research.
[42] T. Giese,et al. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. , 2003, Cancer research.
[43] S. Liang,et al. IFNα regulates NK cell cytotoxicity through STAT1 pathway , 2003 .
[44] M. Colonna,et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas , 2003, The Journal of pathology.
[45] P. Delvenne,et al. Detection of Bone Sialoprotein in Human (Pre)neoplastic Lesions of the Uterine Cervix , 2003, Calcified Tissue International.
[46] B. Wiedenmann,et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. , 2003, Journal of the National Cancer Institute.
[47] M. Bianchi,et al. The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.
[48] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[49] John M. Kirkwood,et al. Cancer immunotherapy: The interferon-α experience , 2002 .
[50] T. Curiel,et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells , 2001, Nature Medicine.
[51] M. Chiasson,et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. , 2000, JAMA.
[52] A. Mantovani,et al. Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3α from Lung Dendritic Cells , 1997, The Journal of experimental medicine.
[53] J. Blay,et al. Impaired IFNa Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression , 2012 .
[54] Herbert J Zeh,et al. High-mobility group box 1 and cancer. , 2010, Biochimica et biophysica acta.
[55] F. Belardelli,et al. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. , 2007, Biochimie.
[56] K. Tracey,et al. High Mobility Group B1 Protein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists , 2006 .
[57] S. Liang,et al. IFNalpha regulates NK cell cytotoxicity through STAT1 pathway. , 2003, Cytokine.
[58] John Kirkwood,et al. Cancer immunotherapy: the interferon-alpha experience. , 2002, Seminars in oncology.